Table 1.

Clinicopathologic characteristics of all patients and comparison between mRNA (CEA or CK20) expression-positive and -negative patients, based on samples collected at the post-mobilization time-point

CEA, carcinoembryonic antigen; CK20, cytokeratin-20.

^a)Values are presented as mean (SD).